Concepedia

Andrew Wighton

AW

Statistics

Publications

3

Citations

226

H-Index

3

Active since

2011

Affiliations

Orion Corporation (United Kingdom)(Current)

Orion Corporation (Finland)

Andrew Wighton is an author at Orion Corporation (United Kingdom) specializing in pharmacology, dexmedetomidine pharmacology, and pharmacokinetics in critical illness.

Publications per year

2011–2016

3

Publications

3

Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients

Timo Iirola, Riku Aantaa, Ruut Laitio et al. · Critical Care · 2011 · 90 citations · Full text

, , +13

Effects of dexmedetomidine and propofol on patient-ventilator interaction in difficult-to-wean, mechanically ventilated patients: a prospective, open-label, randomised, multicentre study

Giorgio Conti, V. Marco Ranieri, Roberta Costa et al. · Critical Care · 2016 · 90 citations · Full text

, , +17

Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients

Pyry A. J. Välitalo, Tuula Ahtola-Sätilä, Andrew Wighton et al. · Clinical Drug Investigation · 2013 · 46 citations · Full text

, , +15

1–3 of 3